ABY-035
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ABY-035, covering 2018-03-02 to 2024-02-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis [Phase 2]